The Ensign Group, Inc. — Earnings Quality Grade F
ENSG · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 46 days, change -3 days YoY
AR growth 11.8% vs revenue growth 18.7%
Revenue 18.7%, CFFO 62.5%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth 22.3% vs revenue 18.7%. Normal
SG&A/Gross Profit = 33.8%. Normal
Gross margin 15.8%, change +0.1pp. Stable
Cash Flow Quality
CFFO/NI = 1.64. Profits backed by cash
FCF $0.4B, FCF/NI = 1.08
Accruals ratio = -4.0%. Low accruals
Cash $0.6B covers only 26% of debt $2.2B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 5% of equity. Manageable
Debt/EBITDA = 3.9x. Healthy
Other assets -10.5% vs revenue 18.7%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -1% YoY. Normal
Manipulation Score
M-Score = -2.59 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor ENSG continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25